A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

Completed · Phase 3 · Has a placebo group

Conditions studied: Heart Failure, Respiratory Insufficiency, Stroke Acute, Infectious Diseases, Rheumatic Diseases

In brief

The purpose of this study is to evaluate the efficacy and safety of rivaroxaban compared with placebo in the prevention of symptomatic venous thromboembolism (VTE) events and VTE-related death post-hospital discharge in high-risk, medically ill patients.

Key facts

Study ID

NCT02111564

Run by

Janssen Research & Development, LLC

People needed

12024

Starts

2014-01-07

Expected to finish

2018-05-03

Last updated by the study team

2019-11-25

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Mobile, Alabama, United States
• Study site — Sheffield, Alabama, United States
• Study site — Scottsdale, Arizona, United States
• Study site — Fort Smith, Arkansas, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Anaheim, California, United States
• Study site — Beverly Hills, California, United States
• Study site — Fullerton, California, United States
• Study site — Los Angeles, California, United States
• Study site — Newport Beach, California, United States
• Study site — Orange, California, United States
• Study site — Sacramento, California, United States
• Study site — San Jose, California, United States
• Study site — San Marino, California, United States
• Study site — Santa Ana, California, United States
• Study site — Colorado Springs, Colorado, United States
• Study site — Bridgeport, Connecticut, United States
• Study site — Danbury, Connecticut, United States
• Study site — New Haven, Connecticut, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Atlantis, Florida, United States
• Study site — Bay Pines, Florida, United States
• Study site — Bradenton, Florida, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.